Search Results
Mar 31, 2026, 13:00 ET Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies
Vlasic Labs today announced that its CBD product line meets the current qualifications outlined in the
More news about: Vlasic Labs
Mar 31, 2026, 10:20 ET Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio
More news about: Innocan Pharma Corporation
Mar 31, 2026, 10:20 ET Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio
More news about: Innocan Pharma Corporation
Mar 31, 2026, 09:04 ET Innovation is spreading across an ever-wider range of cities globally, intensifying competition for premium real estate
innovation hubs such as Beijing, Boston, New York and Seoul. Acute shortages in cities such as Paris and London have led new-build central business district (CBD) vacancy rates to fall to 0.9% and 1.2%, respectively."The geography of innovation has fundamentally changed, with talent and capital dispersing
More news about: JLL
Mar 31, 2026, 07:07 ET Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results
full-spectrum CBD extracts as well as broad-spectrum CBD and cannabinoid isolates. The Company's hemp extracts have naturally occurring botanical compounds including cannabidiol ("CBD"), CBN, CBC, CBG, THC, terpenes, flavonoids, and other beneficial compounds. Charlotte's Web product categories include CBD oil
More news about: Charlotte's Web Holdings, Inc.
Mar 31, 2026, 03:00 ET Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
improve patients' quality of life. This segment includes its primary drug delivery technology, LPT-CBD loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two
More news about: Innocan Pharma Corporation
Mar 31, 2026, 03:00 ET Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
improve patients' quality of life. This segment includes its primary drug delivery technology, LPT-CBD loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two
More news about: Innocan Pharma Corporation
Mar 30, 2026, 22:59 ET Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet
Company's product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery), CBN gummies, CBG gummies, hemp-derived THC microdose gummies, functional mushroom gummies, CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its
More news about: Charlotte's Web Holdings, Inc.
Mar 30, 2026, 10:14 ET CurePSP Convenes Bipartisan Congressional Briefing to Advance PSP, CBD and MSA Research
bringing together lawmakers, scientists and people affected by progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy (PSP, CBD and MSA).
More news about: CurePSP, Inc.
Mar 26, 2026, 16:49 ET MNG Brands Launches Emergency $50,000 "Texas Hemp Retailer Relief Program" to Support Small Businesses Across Texas
national leader in functional wellness retail and product innovation, operating one of the largest privately owned CBD and kratom platforms in the United States. Its flagship retail brand, CBD Kratom, spans more than 50 locations across major markets, including Dallas, Houston, New York, Philadelphia, Chicago,
More news about: MNG Brands
Mar 26, 2026, 15:43 ET MNG Missouri Holdings Responds to Missouri Attorney General Cease and Desist Letter
March 26, 2026 /PRNewswire/ -- On March 17, 2026, MNG Missouri Holdings, LLC (d/b/a CBD Kratom) received a cease and desist letter from the Missouri Attorney General's Office regarding its CBD Kratom Tower Grove location. The letter alleges that certain products exceed the federally legal
More news about: CBD Kratom
Mar 26, 2026, 15:37 ET MASSAGE ENVY BUILDS ON 2025 MOMENTUM AHEAD OF ANNUAL PERFORMANCE SUMMIT
into the technology-driven service and guests incorporated LED treatments into their broader wellness routines. Additional body care options such as CBD and Customized Cupping also gained popularity over the past year, giving therapists more tools to tailor sessions to individual needs.As part
More news about: Massage Envy
Mar 26, 2026, 09:43 ET Nuevo informe: la enfermedad de Parkinson costó a EE.UU. $82,200 millones en 2024, superando proyecciones anteriores
mitigar esta creciente carga económica en la comunidad de EP y nuestro país"."Estos hallazgos ponen en relieve la carga económica total de PSP, CBD y MSA, incluyendo los costos indirectos que a menudo pasamos por alto pero que son parte del apoyo que requieren las familias y los cuidadores", dijo
More news about: The Michael J. Fox Foundation for Parkinson's Research
Mar 26, 2026, 09:00 ET New Report: In 2024, Parkinson's Disease Cost the U.S. $82.2 Billion, Surpassing Previous Projections
this ever-increasing economic burden on the PD community and our country.""These findings bring into focus the full economic burden of PSP, CBD and MSA, including the often overlooked indirect costs borne by families and care partners," said Kristophe Diaz, PhD, Chief Executive Officer of CurePSP.
More news about: The Michael J. Fox Foundation for Parkinson's Research
Mar 24, 2026, 12:10 ET Sunmed™ || Your CBD Store® South Carolina Retailers Warn: H.3924 Will Force Statewide Store Closures and Create a Liquor‑Store Monopoly
many hemp and CBD products into licensed liquor stores.A Monopoly in Disguise: Rather than regulating hemp and CBD, the Bill transfers an entire industry's revenue to the liquor sector.Harms Seniors, Veterans and Families: Many CBD customers are seniors,
More news about: Sunmed
Mar 24, 2026, 09:15 ET Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice
Company's product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery), CBN gummies, CBG gummies, hemp-derived THC microdose gummies, functional mushroom gummies, CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its
More news about: Charlotte's Web Holdings, Inc.
Mar 24, 2026, 08:40 ET Compliant Cannabis Seed Websites on Wix Are Switching Payment Processors
4.8-star rating on Trustpilot, where numerous merchants in e-commerce, CBD, supplements, telehealth, and seed industries have left reviews praising responsive personal support and reliable integrations. The company has processed
More news about: Organic Payment Gateways
Mar 20, 2026, 21:53 ET Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products
Company's product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery), CBN gummies, CBG gummies, hemp-derived THC microdose gummies, functional mushroom gummies, CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its
More news about: Charlotte's Web Holdings, Inc.
Mar 17, 2026, 16:00 ET High Tide Reports First Quarter 2026 Financial Results Featuring Record Revenue Exceeding $700 Million Annualized
begun exploring pathways for its U.S. CBD brands, NuLeaf Naturals and FAB CBD, to participate in and capitalize on recently announced U.S. federal initiatives, including the anticipated launch of a Medicare pilot program that would allow eligible seniors to receive CBD products at no cost up to US$500 annually.
More news about: High Tide Inc.
Mar 16, 2026, 17:03 ET Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio
More news about: Innocan Pharma Corporation
Mar 16, 2026, 17:03 ET Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio
More news about: Innocan Pharma Corporation
Mar 16, 2026, 12:37 ET Edible Oils Market size to Surpass USD 321 Billion by 2032, Shows New Maximize Market Research Analysis
Global Forecast to 2032CBD Edibles Market by Product (Gummies, Chocolates, Cookies, Beverages), Distribution Channel (Online, Retail, Direct), Application (Medical, Recreational),
More news about: Maximize Market Research Pvt. Ltd.
Mar 16, 2026, 09:06 ET LEGACY CANNABIS BRAND ANNOUNCES NATIONWIDE PRODUCT EXPANSION
THC, 100mg CBG, 100mg CBN (Sleep Recover)Sleepy Watermelon - 1:2:2, 50mg THC, 100mg CBN, 100mg CBD (Blissful Sleep)Midnight Prickly Pear - 1:1:1, 100mg THC, 100mg CBN, 100mg CBD (Deep Sleep)Jamberry - 1:1, 100mg THC, 100mg CBN (Classic)The new collection joins
More news about: Smokiez Edibles
Mar 11, 2026, 18:42 ET Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio
More news about: Innocan Pharma Corporation
Mar 11, 2026, 18:42 ET Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio
More news about: Innocan Pharma Corporation